These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 605413

  • 1. The effect of dihydroergotoxine-ethanesulphonate (Redergam) on the basal and with 3-(3,4-dihydroxyphenyl)-L-alanine (L-DOPA) stimulated somatotrophic secretion of diabetic patients.
    Dobrew D, Zonew I, Milanow S.
    Ther Hung; 1977; 25(4):145-9. PubMed ID: 605413
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of adrenergic blocking agents on HGH secretion after administration of L-Dopa].
    Ragonese F, Melluso K, Campisi R, Carducci Artenisio A.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1969-74. PubMed ID: 1231881
    [No Abstract] [Full Text] [Related]

  • 3. [Stimulation of growth hormone secretion by the anterior pituitary gland using L-DOPA compared to growth hormone secretion following argine, insulin and sleep].
    Lucke C, Höffken B, Morgner KD.
    Verh Dtsch Ges Inn Med; 1974 Dec 30; 80():1328-30. PubMed ID: 4454413
    [No Abstract] [Full Text] [Related]

  • 4. [Study of growth hormone under the effects of L-dopa in retardation of stature and acromegaly].
    Fossati P, Asfour M, Fourlinnie JC, Cappoen JP, Dalle-Furnari MA, Brion-Brevan B.
    Lille Med; 1976 Nov 30; 19(9):757-65. PubMed ID: 1004102
    [No Abstract] [Full Text] [Related]

  • 5. [Levodopa and somatotropic hormone in diabetes].
    Carducci Artenisio A, Ragonese F, Martelli G, Forte F, Campisi R, Consolo F.
    Boll Soc Ital Biol Sper; 1978 Oct 30; 54(20):1972-7. PubMed ID: 753286
    [No Abstract] [Full Text] [Related]

  • 6. Propranolol enhancement of L-DOPA induced growth hormone stimulation.
    Camanni F, Massara F, Molinatti GM.
    Biomedicine; 1974 Jun 10; 21(6):241-3. PubMed ID: 4441586
    [No Abstract] [Full Text] [Related]

  • 7. Secretion of growth hormone after L-dopa stimulation in patients with renal failure treated with dialyses.
    Kuska J, Kokot F, Sledziński Z.
    Acta Med Pol; 1979 Jun 10; 20(3):217-26. PubMed ID: 517160
    [No Abstract] [Full Text] [Related]

  • 8. [Behavior of HGH after oral administration of L-dopa in normal and obese subjects].
    Carducci Artenisio A, Ragonese F, Albanese MC, Alibrando S, Allegra V.
    Boll Soc Ital Biol Sper; 1974 Aug 30; 50(13):946-52. PubMed ID: 4463984
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of L-DOPA, phentolamine, aminophylline and propranolol on growth hormone secretion in patients with normal anterior pituitary function and subjects with acromegaly].
    De la Fuente E, Souvatzoglou A, von Werder K.
    Verh Dtsch Ges Inn Med; 1974 Aug 30; 80():1325-8. PubMed ID: 4454412
    [No Abstract] [Full Text] [Related]

  • 10. Study on growth hormone and prolactin secretions in myotonic dystrophy.
    Canal N, Smirne S, Comi G, Guidobono F, Pecile A, Caviezel F.
    Acta Neurol Belg; 1982 Aug 30; 82(3):178-84. PubMed ID: 7051737
    [Abstract] [Full Text] [Related]

  • 11. Effect of hyperglycemia on the growth hormone response to L-dopa in diabetic subjects.
    Barbarino A, De Marinis L, Martino F.
    J Endocrinol Invest; 1978 Jul 30; 1(3):259-61. PubMed ID: 756876
    [Abstract] [Full Text] [Related]

  • 12. L-dopa stimulation of glucagon secretion in man.
    Rayfield EJ, George DT, Eichner HL, Hsu TH.
    N Engl J Med; 1975 Sep 18; 293(12):589-91. PubMed ID: 1152893
    [No Abstract] [Full Text] [Related]

  • 13. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP, Christensen SE, Lundbaek K.
    Scand J Clin Lab Invest; 1975 May 18; 35(3):205-10. PubMed ID: 1153917
    [Abstract] [Full Text] [Related]

  • 14. The effect of L-dopa with and without decarboxylase inhibitor on growth hormone secretion in children with short stature.
    Fevang FO, Stoa RF, Thorsen T, Aarskog D.
    Acta Paediatr Scand; 1977 Jan 18; 66(1):81-4. PubMed ID: 831384
    [Abstract] [Full Text] [Related]

  • 15. Diminished growth hormone secretion in blind males after L-dopa stimulation.
    Fatranská M, Jurcovicová J, Németh S, Vigas M.
    Endocrinol Exp; 1988 Dec 18; 22(4):243-8. PubMed ID: 3243205
    [Abstract] [Full Text] [Related]

  • 16. [Method of determination of somatotropin level in blood plasma with L-dopa loading in patients with diabetes mellitus complicated by microangiopathies].
    Babakhanov KhB.
    Lab Delo; 1975 Dec 18; (10):605-7. PubMed ID: 54462
    [No Abstract] [Full Text] [Related]

  • 17. Endurance exercise modulates levodopa induced growth hormone release in patients with Parkinson's disease.
    Müller T, Welnic J, Woitalla D, Muhlack S.
    Neurosci Lett; 2007 Jul 11; 422(2):119-22. PubMed ID: 17590511
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone.
    Giusti M, Marini G, Sessarego P, Peluffo F, Valenti S, Caratti C, Giordano G.
    Recenti Prog Med; 1991 Dec 11; 82(12):665-8. PubMed ID: 1815302
    [Abstract] [Full Text] [Related]

  • 19. [Prevention with sulpiride of the inhibitory effect of L-DOPA on prolactin secretion].
    Rolandi E, Barreca T, Masturzo P, Polleri A.
    Boll Soc Ital Biol Sper; 1975 Jun 30; 51(12):751-4. PubMed ID: 1222097
    [No Abstract] [Full Text] [Related]

  • 20. [A low response of pituitary growth hormone secretion in the patient with diabetes mellitus after intravenous administration of L-dopa (author's transl)].
    Shimoda S, Takemura Y, Ieiri T, Kasai K, Kikuchi T.
    Nihon Naibunpi Gakkai Zasshi; 1975 Jan 20; 51(1):9-17. PubMed ID: 1171032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.